Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intellia Therapeutics Inc shares valued at $6,104 were sold by Clark Eliana on Mar 04 ’25. At $8.99 per share, Clark Eliana sold 679 shares. The insider’s holdings dropped to 95,369 shares worth approximately $0.94 million following the completion of this transaction.
Also, BASTA JAMES sold 2,572 shares, netting a total of over 23,122 in proceeds. Following the sale of shares at $8.99 each, the insider now holds 111,925 shares.
Before that, Bhanji Muna had sold 265 shares from its account. In a trade valued at $2,642, the Director traded Intellia Therapeutics Inc shares for $9.97 each. Upon closing the transaction, the insider’s holdings decreased to 265 shares, worth approximately $0.19 million.
As published in their initiating research note from H.C. Wainwright on March 05, 2025, Intellia Therapeutics Inc [NTLA] has been a Buy and the price target has been revised to $30. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late February. As of February 28, 2025, Goldman has decreased its “Neutral” rating to a “Sell” for NTLA. Earlier on January 27, 2025, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for NTLA stock which previously was a “an Overweight”.
Analyzing NTLA Stock Performance
During the last five days, there has been a drop of approximately -8.84%. Over the course of the year, Intellia Therapeutics Inc shares have dropped approximately -15.09%. Shares of the company reached a 52-week high of $13.34 on 01/07/25 and a 52-week low of $8.30 on 03/04/25. A 50-day SMA is recorded $10.73, while a 200-day SMA reached $18.12.
Support And Resistance Levels for Intellia Therapeutics Inc (NTLA)
According to the 24-hour chart, there is a support level at 9.18, which, if violated, would cause prices to drop to 8.46. In the upper region, resistance lies at 10.31. The next price resistance is at 10.72. RSI (Relative Strength Index) is 44.78 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.31, which suggests the price will decrease in the coming days. Percent R is at 64.76%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
